Medical Condition News

RSS

Less-toxic combination of immune-based drug and chemotherapy drug produce long-term remissions in CLL

New research shows that a less-toxic combination of a targeted immune-based drug and a chemotherapy drug can produce long-term remissions in some chronic lymphocytic leukemia patients. And it does so without increasing the risk of later therapy-related myelodysplastic syndrome and acute myeloid leukemia, which can often occur with a three-drug combination used to treat these patients.

25 Feb 2011

Takeda receives Japanese approval for additional indications for NESINA

Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited's applications for two additional indications for "NESINA®" (alogliptin), combination therapy with sulfonylurea and combination therapy with biguanide for type 2 diabetes, were approved by the Japanese Ministry of Health, Labour and Welfare.

25 Feb 2011

Medtronic acquires chitosan-dextran gel technology for use in functional endoscopic sinus surgery

Medtronic, Inc. today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research & Innovation Pty Ltd. in Australia, Robinson Squidgel Ltd., and Otago Innovation Ltd. in New Zealand. Medtronic is acquiring this technology for potential use in developing future products for functional endoscopic sinus surgery (FESS).

25 Feb 2011

Neoprobe's Lymphoseek Phase 2 study data published in Annals of Surgical Oncology

Neoprobe Corporation (NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that results from a Phase II study of Lymphoseek® (Tilmanocept) have been published online in the Annals of Surgical Oncology and demonstrate the tracing agent's ability to identify tumor-draining lymph nodes in breast cancer and melanoma patients.

25 Feb 2011

Preclinical data of Zalicus sodium channel compound published in journal PAIN

Zalicus Inc. today announced the publication of preclinical data in the journal PAIN. The paper describes the activity of Z212, a novel proprietary small organic compound that acts to modulate Nav1.7 and Nav1.8 sodium channels and to reduce neuropathic pain by targeting the hyper-excitability associated with chronic pain signaling pathways.

25 Feb 2011

Medwell commits $2,000,000 investment in Mimetogen

Medwell Capital Corp. today announced that it has committed to invest up to $2,000,000 in Mimetogen Pharmaceuticals Inc. ("Mimetogen"), a privately-held, clinical-stage company developing a treatment for dry eye disease. Medwell Capital participated in a Series B equity financing with existing Mimetogen investors, iNovia Capital, MSBi Valorisation and VIMAC Milestone Medica.

25 Feb 2011

Stink bugs may worsen asthma, cause allergy

How rude! They sneak into your home uninvited and when you scare or smush them, they release a foul-smelling substance. "When stink bugs pop up in homes, do they cause allergy? There's not a lot of public information about it," says Nancy Sander, founder and president of Allergy & Asthma Network Mothers of Asthmatics (AANMA), the leading national family-founded nonprofit organization for people with asthma, allergies and related conditions. "So AANMA asked an allergist who knows."

25 Feb 2011

NASA certifies Superfocus glasses for astronauts with presbyopia

Superfocus LLC, creators of Superfocus glasses (formerly known as TruFocals) the first adjustable-focus eyeglasses to treat presbyopia, announced today the flight certification of Superfocus by the National Aeronautics and Space Administration (NASA) for use by astronauts on Discovery's final spaceflight (STS-133) and aboard the International Space Station.

25 Feb 2011

First Super Glue, then dentist

In preparation for the Chicago Dental Society's 146th annual Midwinter Meeting, which will draw more than 30,000 dental professionals to Chicago this February, society members were asked about current trends, dental care tips and more. More than 300 of the society's member dentists responded to the fall 2010 survey.

25 Feb 2011

Enrollment commences in NORDIC implantable cardioverter defibrillator clinical trial

BIOTRONIK SE & Co. KG announced today the start of the NORDIC ICD clinical trial. The first implantable cardioverter defibrillator (ICD) patients were enrolled by its coordinating clinical investigator, Prof. Dr. Dietmar Bänsch at the University Hospital of Rostock and the investigator Dr. Stefan Kuster at the DRK Hospital of Mölln/Ratzeburg.

25 Feb 2011

New study discloses mechanism controlling Rb2/p130 gene expression in lung cancer cells

Despite innumerable studies on lung cancer, many aspects of the disease have yet to be understood, including the role played by the retinoblastoma-related protein Rb2/p130 in the evolution of the disease.

25 Feb 2011

Discovery highlights unexpected role for killer protein in 'autophagy'

Scientists at Trinity College Dublin have made an important discovery concerning how fledgling cancer cells self-destruct, which has the potential of impacting on future cancer therapies. The Trinity research group, led by Smurfit Professor of Medical Genetics, Professor Seamus Martin and funded by Science Foundation Ireland, has just published their findings in the internationally renowned journal, Molecular Cell.

25 Feb 2011

Savient launches KRYSTEXXA in the U.S.

Savient Pharmaceuticals, Inc. announced the official full U.S. commercial launch of KRYSTEXXA™ (pegloticase), which has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic gout in adult patients refractory to conventional therapy. KRYSTEXXA is now the first and only therapy available to address this unmet medical need.

25 Feb 2011

Stallergenes inaugurates new pollen-production factory

On 20 January, Stallergenes, the leading company worldwide in sublingual immunotherapy treatments for respiratory allergies, inaugurated its new pollen-production site in Amilly (Loiret department).

25 Feb 2011

Dizziness, nausea and achiness are symptoms of heart attack in females

Dizziness, nausea and achiness – no, these are not symptoms of the flu but signs of a heart attack in females. While heart attacks affect both men and women, the symptoms of a heart attack are surprisingly different between the genders. Virginia Health Information (VHI) this week released its Cardiac Care Report which provides consumers information comparing heart healthcare in Virginia. This year's report reveals women undergoing open heart surgery continued a five year trend of higher than expected readmission rates.

25 Feb 2011

Study investigates risk of dysphagia after radiotherapy treatment for head & neck cancer

At the 3rd International Conference on innovative approaches in Head and Neck Oncology (ICHNO), Dr Hanna Rahbek Mortensen and colleagues at hospitals and institutes in Denmark presented results from a large prospective trial, the DAHANCA 6 & 7 study. The study, conducted across the country, investigated risk factors for developing dysphagia (swallowing dysfunction), after undergoing radiotherapy treatment for a head & neck cancer.

25 Feb 2011

Protalix receives FDA CRL for taliglucerase alfa NDA for Gaucher disease

Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).

25 Feb 2011

Meditation leads to stronger mind-body connection than dancing

The body is a dancer's instrument, but is it attuned to the mind? A new study from the University of California, Berkeley, suggests that professional ballet and modern dancers are not as emotionally in sync with their bodies as are people who regularly practice meditation.

25 Feb 2011

Evolutionary changes may have influenced metabolism and increased risk of diabetes

Researchers at the University of California, San Diego School of Medicine and Rady Children's Hospital-San Diego say an evolutionary gene mutation that occurred in human millions of years ago and our subsequent inability to produce a specific kind of sugar molecule appears to make people more vulnerable to developing type 2 diabetes, especially if they're overweight.

25 Feb 2011

Research sheds new light on problem of insulin resistance in type 2 diabetes

A research team, led by La Jolla Institute scientist Joel Linden, Ph.D., has shed new light on the problem of insulin resistance, and identified the key participants in a molecular pathway that holds therapeutic promise for reducing the severity of type 2 diabetes.

25 Feb 2011

Medical Condition News

Less-toxic combination of immune-based drug and chemotherapy drug produce long-term remissions in CLL

Takeda receives Japanese approval for additional indications for NESINA

Medtronic acquires chitosan-dextran gel technology for use in functional endoscopic sinus surgery

Neoprobe's Lymphoseek Phase 2 study data published in Annals of Surgical Oncology

Preclinical data of Zalicus sodium channel compound published in journal PAIN

Medwell commits $2,000,000 investment in Mimetogen

Stink bugs may worsen asthma, cause allergy

NASA certifies Superfocus glasses for astronauts with presbyopia

First Super Glue, then dentist

Enrollment commences in NORDIC implantable cardioverter defibrillator clinical trial

New study discloses mechanism controlling Rb2/p130 gene expression in lung cancer cells

Discovery highlights unexpected role for killer protein in 'autophagy'

Savient launches KRYSTEXXA in the U.S.

Stallergenes inaugurates new pollen-production factory

Dizziness, nausea and achiness are symptoms of heart attack in females

Study investigates risk of dysphagia after radiotherapy treatment for head & neck cancer

Protalix receives FDA CRL for taliglucerase alfa NDA for Gaucher disease

Meditation leads to stronger mind-body connection than dancing

Evolutionary changes may have influenced metabolism and increased risk of diabetes

Research sheds new light on problem of insulin resistance in type 2 diabetes

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News